Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.
Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. Stutterheim J, et al. Among authors: van noesel mm, van der schoot ce. J Clin Oncol. 2008 Nov 20;26(33):5443-9. doi: 10.1200/JCO.2007.13.6531. Epub 2008 Oct 6. J Clin Oncol. 2008. PMID: 18838715
Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.
Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel MM, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. Stutterheim J, et al. Among authors: van noesel mm, van der schoot ce. Clin Chem. 2009 Jul;55(7):1316-26. doi: 10.1373/clinchem.2008.117945. Epub 2009 May 21. Clin Chem. 2009. PMID: 19460840 Free article.
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia.
Waanders E, van der Velden VH, van der Schoot CE, van Leeuwen FN, van Reijmersdal SV, de Haas V, Veerman AJ, van Kessel AG, Hoogerbrugge PM, Kuiper RP, van Dongen JJ. Waanders E, et al. Among authors: van der velden vh, van reijmersdal sv, van dongen jj, van leeuwen fn, van der schoot ce, van kessel ag. Leukemia. 2011 Feb;25(2):254-8. doi: 10.1038/leu.2010.275. Epub 2010 Nov 19. Leukemia. 2011. PMID: 21102428
Stability of PCR targets for monitoring minimal residual disease in neuroblastoma.
Stutterheim J, Zappeij-Kannegieter L, Ora I, van Sluis PG, Bras J, den Ouden E, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA. Stutterheim J, et al. Among authors: van der schoot ce, van sluis pg. J Mol Diagn. 2012 Mar-Apr;14(2):168-75. doi: 10.1016/j.jmoldx.2011.12.002. Epub 2012 Jan 16. J Mol Diagn. 2012. PMID: 22251610 Free article.
Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia.
Denys B, van der Sluijs-Gelling AJ, Homburg C, van der Schoot CE, de Haas V, Philippé J, Pieters R, van Dongen JJ, van der Velden VH. Denys B, et al. Among authors: van der velden vh, van dongen jj, van der schoot ce, van der sluijs gelling aj. Leukemia. 2013 Mar;27(3):635-41. doi: 10.1038/leu.2012.231. Epub 2012 Aug 16. Leukemia. 2013. PMID: 22945774
354 results